Does current evidence justify prostate cancer screening in Europe?

Nat Clin Pract Oncol. 2005 Nov;2(11):538-9. doi: 10.1038/ncponc0349.
No abstract available

MeSH terms

  • Europe / epidemiology
  • Humans
  • Male
  • Mass Screening*
  • Predictive Value of Tests
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / epidemiology
  • Sensitivity and Specificity
  • United Kingdom / epidemiology

Substances

  • Prostate-Specific Antigen